JamesDMcGovernMD

Physician

Are you Dr. McGovern?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 36 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Dr. James McGovern, MD is an oncologist in Green Bay, Wisconsin. He is currently licensed to practice medicine in Wisconsin and Michigan.

PubMed

6 citations
Phase I/II Study of Gemcitabine and Exisulind as Second-Line Therapy in Patients with Advanced Non–small Cell Lung Cancer
Tien Hoang, KyungMann Kim, Joseph Merchant, Anne M. Traynor, James McGovern, Kurt R. Oettel, Fredrico A. Sanchez, Harish Ahuja, Thomas A. Hensing, Martha M. Larson, Jo...> ;Journal of Thoracic Oncology. 2006 Mar 1
14 citations
Phase II study of weekly low-dose paclitaxel for relapsed and refractory non-Hodgkin's lymphoma: a Wisconsin Oncology Network Study.
Brad S. Kahl, Howard H. Bailey, Eileen P. Smith, Nancy Turman, Jamie Smith, Jae Werndli, Eliot C. Williams, Walter L. Longo, KyungMann Kim, James McGovern, Alcee Jumon...> ;Cancer Investigation. 2005 Jan 1
45 citations
Phase II study of second-line gemcitabine in sensitive or refractory small cell lung cancer.
Tien Hoang, KyungMann Kim, Anthony Jaslowski, Paul L. Koch, Peter A. Beatty, James McGovern, Maria Quisumbing, Gary Shapiro, Robert S. Witte, Joan H. Schiller> ;Lung Cancer. 2003 Oct 1
41 citations
Phase II trial of perillyl alcohol (NSC 641066) administered daily in patients with metastatic androgen independent prostate cancer.
Glenn Liu, Kurt R. Oettel, Howard H. Bailey, Lynn Van Ummersen, Kendra D. Tutsch, Mary Jane Staab, Dorothea Horvath, Dona Alberti, Rhoda Z. Arzoomanian, Hamied Rezazad...> ;Investigational New Drugs. 2003 Aug 1
Join now to see all